Prokidney (PROK) Change in Interest Receivables (2023 - 2026)
Prokidney (PROK) reported Change in Interest Receivables of -$95000.0 for Q1 2026, up 86.33% year-over-year from -$50984.6 in Q1 2025, and up 13.64% quarter-over-quarter from -$110000.0 in Q4 2025.
Prokidney (PROK) Change in Interest Receivables (2023 - 2026) Analysis & Trends
Prokidney (PROK) has 4 years of Change in Interest Receivables data on file, last reported at -$95000.0 in Q1 2026.
- Change in Interest Receivables for Q1 2026 came in at -$95000.0, up 86.33% year-over-year; the trailing twelve-month figure through Mar 2026 was -$720000.0 (down 373.68% YoY), and the FY2025 annual result was -$1.3 million, down 223.13% from the prior year.
- Change in Interest Receivables climbed to -$95000.0 in Q1 2026 per PROK's latest filing, from -$110000.0 in the prior quarter.
- Over five years, Change in Interest Receivables peaked at $5.5 million in Q1 2023 and troughed at -$7.4 million in Q3 2023.
- A 4-year average of $79384.6 and a median of $23000.0 in 2025 frame the typical range for Change in Interest Receivables.
- On a YoY basis, Change in Interest Receivables climbed as much as 131.93% in 2024 and fell as far as 501.82% in 2024.
- A 4-year view of Change in Interest Receivables shows it stood at $661000.0 in 2023, then slumped by 501.82% to -$2.7 million in 2024, then soared by 95.86% to -$110000.0 in 2025, then gained by 13.64% to -$95000.0 in 2026.
- Business Quant data shows PROK's Change in Interest Receivables at -$95000.0 in Q1 2026, -$110000.0 in Q4 2025, and -$538000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Interest Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Prokidney | 259.01 Mn | 1.55 Bn | - | -95,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -95,000.00 |
| Dec 31, 2025 | -110,000.00 |
| Sep 30, 2025 | -538,000.00 |
| Jun 30, 2025 | 23,000.00 |
| Mar 31, 2025 | -695,000.00 |
| Dec 31, 2024 | -2.66 Mn |
| Sep 30, 2024 | 2.36 Mn |
| Jun 30, 2024 | 844,000.00 |
| Mar 31, 2024 | 529,000.00 |
| Dec 31, 2023 | 661,000.00 |
| Sep 30, 2023 | -7.38 Mn |
| Jun 30, 2023 | 2.61 Mn |
| Mar 31, 2023 | 5.48 Mn |